GLP-1 Medications Linked to Complications: Ozempic, Wegovy, Trulicity

Did you experience significant intestinal and/or stomach complications including but not limited to gastroparesis (paralysis of the stomach) and ileus after taking Ozempic, Wegovy, Trulicity, Saxenda, Victoza or Rybelsus?  If so, you may be entitled to compensation.

GLP-1 Intestine and Stomach Paralysis Complications

The weight loss and diabetes drug lawyers here at Mazie Slater are investigating claims of serious side effects and complications in people who utilized certain glucagon-like peptide 1 (GLP-1) receptor agonist (RA) medications, for diabetes and weight loss. Our investigation indicates that the pharmaceutical manufacturers of these medications, including Novo Nordisk, failed to adequately warn of these severe intestinal and stomach complications that can be caused by these drugs, causing severe and permanent injuries in many people.  Novo Nordisk is headquartered in New Jersey, where Mazie Slater is based.

Serious side effects and complications of these weight loss and diabetic medications may include:

  • Gastroparesis (paralysis of the stomach)
  • Ileus
  • Pancreatitis
  • Bowel Obstruction (Blocked Intestine)
  • Aspiration

Weight Loss & Diabetes Medications Linked to Complications

A recent Case Report published in January 2024, discussed semaglutide’s known gastrointentstinal advers effects, and highlighted “the need [for medical providers] to recognize medication-induced gastroparesis as a possible diagnosis, especially in individuals with risk factors.”

Some of the medications that have been linked to these serious disorders include:

  • Ozempic (semaglutide)
  • Wegovy (semaglutide)
  • Rybelsus (semaglutide)
  • Trulicity (dulaglutide)
  • Saxenda (liraglutide)
  • Victoza (liraglutide)

People who were treated in the emergency room, hospitalized or  treated by a gastroenterologist, due to gastroparesis or bowel obstruction, who were diagnosed with ileus or pancreatitis or who aspirated during surgery or while under anesthesia after using one of these drugs may be eligible for compensation. 

Weight Loss & Diabetes Drug Injury Lawyers

In October 2023, The Journal of the American Medical Association(JAMA), examined adverse events in patients with diabetes associated with GLP-1 RA in a research letter called “Risk of Gastrointestinal Adverse Events Associated With Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss” where it concluded that studies have found increased risks of gastrointestinal adverse events, such as biliary disease, pancreatitis, bowel obstruction, and gastroparesis.

Additionally, A recent report from CNN discussed patients aren’t just experiencing minor stomach symptoms due to some of these the weight loss drugs, their stomachs are apparently completely paralyzed. After a year of taking Ozempic injections, both patients reportedly became extremely ill, including symptoms of severe vomiting and an inability to eat. They were eventually diagnosed with severe gastroparesis, or “paralyzed stomachs.”

Who is Eligible to File a Ozempic, Wegovy, Rybelsus, Trulicity, Saxenda or Victoza Lawsuit?

If you or a loved one was prescribed Ozempic, Wegovy, Rybelsus, Trulicity, Saxenda or Victoza from a doctor that was purchased from a retail pharmacy and have suffered significant, permanent stomach or intestinal issues, you may have a claim.  Mazie Slater is based in New Jersey, the same state where Novo Nordisk is based. Contact our Ozempic Lawyers today for a free consultation.  We are not investigating claims on behalf of people who purchased unbranded versions of these medications made at a compounding pharmacy, which are often sold by “med spas” or other types of “health clinics.”

GLP-1 Medications Linked to Complications: Ozempic, Wegovy, Trulicity

Did you experience significant intestinal and/or stomach complications including but not limited to gastroparesis (paralysis of the stomach) and ileus after taking Ozempic, Wegovy, Trulicity, Saxenda, Victoza or Rybelsus?  If so, you may be entitled to compensation.

GLP-1 Intestine and Stomach Paralysis Complications

The weight loss and diabetes drug lawyers here at Mazie Slater are investigating claims of serious side effects and complications in people who utilized certain glucagon-like peptide 1 (GLP-1) receptor agonist (RA) medications, for diabetes and weight loss. Our investigation indicates that the pharmaceutical manufacturers of these medications, including Novo Nordisk, failed to adequately warn of these severe intestinal and stomach complications that can be caused by these drugs, causing severe and permanent injuries in many people.  Novo Nordisk is headquartered in New Jersey, where Mazie Slater is based.

Serious side effects and complications of these weight loss and diabetic medications may include:

  • Gastroparesis (paralysis of the stomach)
  • Ileus
  • Pancreatitis
  • Bowel Obstruction (Blocked Intestine)
  • Aspiration

Weight Loss & Diabetes Medications Linked to Complications

A recent Case Report published in January 2024, discussed semaglutide’s known gastrointentstinal advers effects, and highlighted “the need [for medical providers] to recognize medication-induced gastroparesis as a possible diagnosis, especially in individuals with risk factors.”

Some of the medications that have been linked to these serious disorders include:

  • Ozempic (semaglutide)
  • Wegovy (semaglutide)
  • Rybelsus (semaglutide)
  • Trulicity (dulaglutide)
  • Saxenda (liraglutide)
  • Victoza (liraglutide)

People who were treated in the emergency room, hospitalized or  treated by a gastroenterologist, due to gastroparesis or bowel obstruction, who were diagnosed with ileus or pancreatitis or who aspirated during surgery or while under anesthesia after using one of these drugs may be eligible for compensation. 

Weight Loss & Diabetes Drug Injury Lawyers

In October 2023, The Journal of the American Medical Association(JAMA), examined adverse events in patients with diabetes associated with GLP-1 RA in a research letter called “Risk of Gastrointestinal Adverse Events Associated With Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss” where it concluded that studies have found increased risks of gastrointestinal adverse events, such as biliary disease, pancreatitis, bowel obstruction, and gastroparesis.

Additionally, A recent report from CNN discussed patients aren’t just experiencing minor stomach symptoms due to some of these the weight loss drugs, their stomachs are apparently completely paralyzed. After a year of taking Ozempic injections, both patients reportedly became extremely ill, including symptoms of severe vomiting and an inability to eat. They were eventually diagnosed with severe gastroparesis, or “paralyzed stomachs.”

Who is Eligible to File a Ozempic, Wegovy, Rybelsus, Trulicity, Saxenda or Victoza Lawsuit?

If you or a loved one was prescribed Ozempic, Wegovy, Rybelsus, Trulicity, Saxenda or Victoza from a doctor that was purchased from a retail pharmacy and have suffered significant, permanent stomach or intestinal issues, you may have a claim.  Mazie Slater is based in New Jersey, the same state where Novo Nordisk is based. Contact our Ozempic Lawyers today for a free consultation.  We are not investigating claims on behalf of people who purchased unbranded versions of these medications made at a compounding pharmacy, which are often sold by “med spas” or other types of “health clinics.”

Read More
Watch Our Attorneys

On Television and in Court

View All Media Media Networks